首页> 外文期刊>European Spine Journal >Could an osteoinductor result in degeneration of a neurofibroma in NF1?
【24h】

Could an osteoinductor result in degeneration of a neurofibroma in NF1?

机译:骨诱导剂会导致NF1神经纤维瘤变性吗?

获取原文
获取原文并翻译 | 示例
       

摘要

We report a case of fatal evolution of neurofibromatosis in a young boy. A laminectomy was performed when he was 9 years old. A secondary hyperkyphosis led to many surgeries resulting in recurrent malunions. When he was 23 years old, a breakage of his rods was treated by a new instrumentation and a T12–L1 interbody cage fitted with rh-BMP. Five months later, he developed a huge posterior tumour on his back. The biopsy diagnosed a neurofibrosarcoma. The growth of the tumour was extremely rapid. He died after several months from a septic shock. NF1 is characterised by neurofibromas that have a possibility of malign degeneration and conversion to a sarcoma. However, the chronology, rapidity of evolution and the exceptional volume of the tumour made us wonder whether the BMP had a part of responsibility as osteoinductor in the malignant degeneration, in this particular case, of neurofibromatosis. It seemed important to point out this case to the medical community.
机译:我们报告了一个小男孩神经纤维瘤病的致命进化案例。他9岁时进行了椎板切除术。继发性后凸畸形导致许多手术导致复发畸形。他23岁那年,他的杆断裂被新仪器和装有rh-BMP的T12–L1椎间融合器治疗。五个月后,他的背部出现了巨大的后部肿瘤。活检诊断为神经纤维肉瘤。肿瘤的生长非常快。他因败血症性休克数月后死亡。 NF1的特征是神经纤维瘤,可能会恶变并转化为肉瘤。但是,随着时间的流逝,演变的速度以及肿瘤的异常体积,我们怀疑BMP在这种神经纤维瘤病的恶性变性中是否作为骨诱导剂起作用。向医学界指出此案似乎很重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号